Pakeeza Sayyed

Sustained Polymeric Delivery of Gene Silencing Antisense ODNs, siRNA, DNAzymes and Ribozymes:<i>In Vitro</i>and<i>In Vivo</i>Studies

Alim Khan, Mustapha Benboubetra, Pakeeza Sayyed et al. · Journal of drug targeting · 2004 · 135 citations

The cellular delivery of antisense oligonucleotides and ribozymes

Marcus D. Hughes, Majad Hussain, Qamar Nawaz et al. · Drug Discovery Today · 2001 · 95 citations

Cellular Delivery, Medicine, Natural Sciences +6

Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study

Antonio Salar, Irit Avivi, Beate Bittner et al. · Journal of Clinical Oncology · 2014 · 92 citations · Full text

Phase Ib Study, Iv Rituximab, Lymphoid Neoplasia +14

Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial

Sarit Assouline, Valéria Buccheri, Alain Delmer et al. · The Lancet Haematology · 2016 · 44 citations

Phase 1B, Lymphoid Neoplasia, Hematological Malignancy +10

Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia

Sarit Assouline, Valéria Buccheri, Alain Delmer et al. · British Journal of Clinical Pharmacology · 2015 · 38 citations · Full text